ATG7 and cholangiocarcinoma: Further studies are needed to examine the effect of mutant ATG7 on levels of reactive oxygen species (ROS) and DNA damage, and also to determine how increased levels of p62 may be linked to cholangiocarcinoma development through the p62-KEAP1-NRF2 axis.